Disease/Infection News

RSS

Study: Integrating palliative care earlier in care trajectory benefits COVID-19 patients

Critical care nurses are ideally positioned to drive full integration of palliative care into the care of all patients who are seriously ill, including patients with COVID-19, according to an article published in the December issue of Critical Care Nurse (CCN).

2 Dec 2020

Elsevier launches a new book on COVID-19

Elsevier, a global research publishing and information analytics provider, recently launched the English version of COVID-19: The Essentials of Prevention and Treatment. A digital version of the book is freely available to download on Elsevier's Novel Coronavirus Information Center here.

2 Dec 2020

New combination therapy may help fight antimicrobial resistance

An inexpensive, FDA-approved drug -- cholestyramine -- taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. The team's findings appear today (Dec. 1) in the journal eLife.

2 Dec 2020

Researchers evaluate the most appropriate test for COVID-19

Until a vaccine is available, curbing the coronavirus pandemic relies heavily on how quickly a potentially exposed individual can be tested and quarantined.

2 Dec 2020

Study evaluates the performance of meningococcus B vaccine in real-world setting

Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero.

2 Dec 2020

Breakthrough in microscopy, endoscopy may soon revolutionize the study of cellular origin of diseases

A breakthrough in microscopy and endoscopy will soon revolutionize the study of the cellular origin of diseases, advancing the field of precision medicine. This is the goal of CRIMSON, a trans-disciplinary and trans-national research project recently funded by European Commission.

2 Dec 2020

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

A team of San Diego Supercomputer Center (SDSC) researchers recently created a pharmacophore model and conducted data mining of the database of drugs approved by the U.S. Federal Drug Administration (FDA) to find potential inhibitors of papain-like protease of SARS-CoV2, one of the main viral proteins responsible for COVID-19.

2 Dec 2020

New research project to develop and test novel intervention for individuals with HIV/AIDS

Tulsa CARES is partnering with researchers at the Hudson College of Public Health at the University of Oklahoma Health Sciences Center and the OU-TU School of Community Medicine at the University of Oklahoma to develop and test a novel "food as medicine" intervention for individuals affected by HIV/AIDS.

2 Dec 2020

Study shows how parasite that causes Chagas disease resists current therapies

New insight on how a parasite can resist current therapies has been published today in the open-access eLife journal.

2 Dec 2020

Immune mechanism in COVID-19 patients triggers cytokine storm

Researchers at the University of São Paulo (USP) in Brazil have demonstrated for the first time that in COVID-19 patients an immune mechanism known as the inflammasome participates in activation of the inflammatory process that can damage several organs and even lead to death.

2 Dec 2020

Study: False widow spiders carry harmful strains resistant to common antibiotic treatments

A team of zoologists and microbiologists from NUI Galway have published a new study showing that common house spiders carry bacteria susceptible to infect people, with the Noble False Widow spiders also carrying harmful strains resistant to common antibiotic treatments.

1 Dec 2020

CARES Act helped reduce social interaction of viral spread

As case rates of COVID-19 reach new heights across the nation, many states and cities are tightening stay-at-home restrictions to stop the spread.

1 Dec 2020

Repurposed mouse model sheds light on spectrum of COVID-19 disease symptoms

A repurposed mouse model can develop symptoms of both severe COVID-19 (lung damage, blood clots, abnormal blood vessels, and death) and also of milder disease, including loss of the sense of smell, according to a recent University of Iowa study published in Nature.

1 Dec 2020

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

In an article published in the journal Virus Research, a team of researchers from various US institutions discussed their study that evaluated the antiviral activity of PTC299 against a group of RNA viruses in vitro.

1 Dec 2020

Alcohol-free hand sanitizer works just as well as alcohol-based products to control COVID-19

A new study from researchers at Brigham Young University finds that alcohol-free hand sanitizer is just as effective at disinfecting surfaces from the COVID-19 virus as alcohol-based products.

1 Dec 2020

Nanomedicine's giant step into the fight against the COVID-19

A recent editorial in Nature Nanotechnology discusses the enormous feat of scientific innovation, with messenger RNA (mRNA)-based vaccines developed to deliver the gene sequence of specific SARS-CoV-2 viral proteins into host cells using nanotechnology platforms.

1 Dec 2020

Older adults may be coping with COVID-19's mental health effects better than other age groups

Older adults are especially vulnerable to the effects of the COVID-19 pandemic--with higher risks of severe complications and death, and potentially greater difficulties accessing care and adapting to technologies such as telemedicine.

1 Dec 2020

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

Researchers in Algeria have reviewed some of the evidence suggesting that flavonols commonly found in many plants and vegetables could be used as a therapeutic approach to coronavirus disease 2019 (COVID-19).

1 Dec 2020

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against Covid-19 based on the yellow fever vaccine, which as a result also works against yellow fever. Results published today in Nature show that the vaccine protects hamsters from infection with the SARS-CoV-2 coronavirus after a single dose.

1 Dec 2020

Does smoking increase risk of COVID-19 hospitalization?

A study conducted by UK researchers has found that patients hospitalized with coronavirus disease 2019 (COVID-19) were less likely to be current smokers than patients who had been admitted with other types of respiratory viral infections last year (2019).

1 Dec 2020

Disease/Infection News

Study: Integrating palliative care earlier in care trajectory benefits COVID-19 patients

Elsevier launches a new book on COVID-19

New combination therapy may help fight antimicrobial resistance

Researchers evaluate the most appropriate test for COVID-19

Study evaluates the performance of meningococcus B vaccine in real-world setting

Breakthrough in microscopy, endoscopy may soon revolutionize the study of cellular origin of diseases

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

New research project to develop and test novel intervention for individuals with HIV/AIDS

Study shows how parasite that causes Chagas disease resists current therapies

Immune mechanism in COVID-19 patients triggers cytokine storm

Study: False widow spiders carry harmful strains resistant to common antibiotic treatments

CARES Act helped reduce social interaction of viral spread

Repurposed mouse model sheds light on spectrum of COVID-19 disease symptoms

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

Alcohol-free hand sanitizer works just as well as alcohol-based products to control COVID-19

Nanomedicine's giant step into the fight against the COVID-19

Older adults may be coping with COVID-19's mental health effects better than other age groups

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

Does smoking increase risk of COVID-19 hospitalization?

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Latest News